Skip to main content
. 2016 Jan 8;17(1):158–166. doi: 10.1120/jacmp.v17i1.5781

Figure 2.

Figure 2

Maximum percentage deviation in D99%, D50%, and D1% dose metrics for the moving GTV between any two starting phases for a single fraction (a) dMLC IMRT and (b) VMAT SABR lung delivery for clinically relevant motion periods (5 s).